Evidence map›Paper›PMID 38399994›Full record

ReviewViruses2024

Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection.

Wenli Mu, Vaibhavi Patankar, Scott Kitchen, Anjie Zhen

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 3 pooled it
23.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wenli MuDivision of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.ORCID 0000-0003-2244-510X
Vaibhavi PatankarDivision of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Scott KitchenDivision of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Anjie ZhenDivision of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
University of California, Los Angeles · US

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZACK, JEROME A. · 1991 to 2018
$39.9M
UCLA-CDU CFARP30AI152501 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCOTT G KITCHEN · 2022 to 2026
$15.6M
Viral Immunology CoreU19AI149504 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHEN, IRVIN S.Y., KITCHEN, SCOTT G · 2020 to 2024
$14.3M
Induction of autophagy to enhance CAR-T cells in HIV cure approachesR01AI172727 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARSDEN, MATTHEW DAVID, ZHEN, ANJIE · 2022 to 2025
$3.9M
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell DeliveryR01AI140775 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G, YANG, OTTO O · 2020 to 2024
$3.8M
Define the effects and mechanism of THC and CBD on IFN-I mediated inflammation and immune dysfunction during HIV infectionR01DA052841 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G, ZHEN, ANJIE · 2020 to 2024
$1.9M
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infectionR01CA239261 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 2019 to 2023
$1.8M
Targeting Autophagy to Restore Anti-HIV T Cell ResponseR21AI140866 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHEN, ANJIE · 2018 to 2019
$429k
NCI NIH HHS R01 CA239261NIAID NIH HHS P30 AI028697NIAID NIH HHS P30 AI152501NIAID NIH HHS R01 AI140775NIAID NIH HHS R01 AI172727NIAID NIH HHS R21 AI140866NIAID NIH HHS U19 AI149504NIDA NIH HHS R01 DA052841NIDA NIH HHS R01DA-52841
6 · The paper itself

Abstract

Chronic Human Immunodeficiency Virus (HIV) infection remains a significant challenge to global public health. Despite advances in antiretroviral therapy (ART), which has transformed HIV infection from a fatal disease into a manageable chronic condition, a definitive cure remains elusive. One of the key features of HIV infection is chronic immune activation and inflammation, which are strongly associated with, and predictive of, HIV disease progression, even in patients successfully treated with suppressive ART. Chronic inflammation is characterized by persistent inflammation, immune cell metabolic dysregulation, and cellular exhaustion and dysfunction. This review aims to summarize current knowledge of the interplay between chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection, and also discusses the use of humanized mice models to study HIV immune pathogenesis and develop novel therapeutic strategies.

Indexed as

HIV-1HIV InfectionsAnimalsHumansInflammationMiceT-Lymphocyteschronic inflammationHIV infectionimmune metabolismT cell dysfunction

Identifiers

PMID38399994
PMCPMC10893210
OpenAlexW4391385982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.